Advent Life Sciences seals KaNDy sale to industry giant Bayer, deal could be worth over $975m

Europe's Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.